Mycosis Fungoides Therapeutics Market Emerging Analysis, Future Growth and Business Opportunities 2027
Mycosis Fungoides Therapeutics Market: Introduction Mycosis fungoides is the most common type of blood cancer known as cutaneous T-cell lymphoma. Cutaneous T-cell lymphoma occurs when certain T-cells become cancerous. These cancers affect the skin and cause different types of lesions on the skin. Mycosis fungoides usually affects the adults over age 50. However, affected children have been identified. According to a study published in the Genetics Home References, an estimated 1 in 100,000 to 350,000 individuals are affected by mycosis fungoides. It accounts for 70% of T-cell lymphomas. Mycosis fungoides affects men nearly twice as often as females. About 3.6 cases per million people each are affected by mycosis fungoides in the U.S. The cause of mycosis fungoides is unidentified. Most of the individuals affected by mycosis fungoides have one or more chromosomal abnormalities, such as gain or loss of genetic material. Appropriate therapy for mycosis fungoides depends on a var...